Home > Healthcare > Biotechnology > Biopharma > Stem Cell Therapy Market

Stem Cell Therapy Market Size

Name: Stem Cell Therapy Market - Size & Share Report, 2032
Creator: Global Market Insights
License: https://www.gminsights.com/privacy-policy

Report ID: GMI3331
Published Date: Feb 2023
Report Format: PDF

Download Free Sample

Stem Cell Therapy Market Size

Stem Cell Therapy Market size was valued at over USD 11.8 billion in 2022. Driven by the increasing occurrence of chronic ailments across the globe, the market is anticipated to grow at over 10% CAGR from 2023 to 2032.

To get key market trends

Download Free Sample

Increasing incidence of chronic disorders such as muscular dystrophy, neurological ailments, cancer, and others in both developed and developing economies is proliferating the demand for advanced experimental medical treatment. The US reported over 608,570 deaths due to cancer and nearly 1.9 million newly diagnosed cases of the disease in 2021 alone. Such high case loads are creating a notable impetus for stem cell-based therapy, fostering stem cell therapy market progress.

Over time, conventional drugs and treatments have demonstrated an efficacy drop when treating chronic ailments such as cancer. Stem cell-based therapies, although still considered experimental, are regarded highly promising when it comes to treating such ailments. In fact, treatments such as mesenchymal stem cell therapy have been proven efficacious in treating inflammatory, degenerative, and autoimmune disorders due to their regenerative potential and immunoregulatory properties.

Stem Cell Therapy Market Report Attributes
Report Attribute	Details
Base Year:	2022
Stem Cell Therapy Market Size in 2022:	USD 11.8 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	10%
2032 Value Projection:	USD 31.5 Billion
Historical Data for:	2018 to 2022
No. of Pages:	120
Tables, Charts & Figures:	241
Segments covered:	Type, Therapeutic area, End-use, and Region
Growth Drivers:	Advancements in regenerative medicine in North America & Europe Increasing government initiatives for stem cell therapy in developed as well as developing countries Rising awareness regarding availability of stem cell therapy in developing countries Growing prevalence of chronic diseases Increasing research and development activities undertaken by companies for stem cell therapy
Pitfalls & Challenges:	High cost of stem cell therapy Ethical issues associated with stem cell therapy

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global stem cell therapy market held a valuation of over USD 11.8 billion in 2022, with Global Market Insights, Inc., projections expecting it to grow at over 10% CAGR from 2023 to 2032, driven by the surging prevalence of chronic ailments worldwide.

Hospitals end use segment was valued as over USD 6.5 billion in 2022, fueled by increasing world government focus on improving hospital infrastructure, the market is set to derive notable growth from the segment.

Europe stem cell therapy industry valuation is expected to witness over USD 8 billion by 2032, on account of the increasing occurrence of neurodegenerative diseases in the region creating a strong demand for stem cell therapies.

Some of the prominent market players include Capricor Therapeutics, Cellectis, FUJIFILM Cellular Dynamics, Inc., DiscGenics, Mesoblast Ltd., ThermoGenesis Holdings, Inc., CHIESI Farmaceutici S.p.A., and GSK plc., among others.